Molecular Genetics of Dopa-Responsive Dystonia
暂无分享,去创建一个
[1] R. Stevens,et al. Structural Insight into the Aromatic Amino Acid Hydroxylases and Their Disease-Related Mutant Forms. , 1999, Chemical reviews.
[2] Takahiro Suzuki,et al. Decrease in GTP cyclohydrolase I gene expression caused by inactivation of one allele in hereditary progressive dystonia with marked diurnal fluctuation. , 1999, Biochemical and biophysical research communications.
[3] H. Ichinose,et al. Neopterin and Cytokines in Hereditary Dystonia and Parkinson's Disease , 1999 .
[4] S. Kuzuhara,et al. A novel de novo point mutation in the GTP cyclohydrolase I gene in a Japanese patient with hereditary progressive and dopa responsive dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[5] C. Marsden,et al. Dopa‐responsive dystonia: A clinical and molecular genetic study , 1998, Annals of neurology.
[6] S. Ueno,et al. Dominant negative effect of GTP cyclohydrolase I mutations in dopa‐responsive hereditary progressive dystonia , 1998, Annals of neurology.
[7] F. Gabreëls,et al. Biochemical hallmarks of tyrosine hydroxylase deficiency. , 1998, Clinical chemistry.
[8] S. Kish,et al. Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations , 1998, Annals of neurology.
[9] N. Risch,et al. De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. , 1998, Human molecular genetics.
[10] R. Wevers,et al. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population , 1998, Human Genetics.
[11] S. Tsuji,et al. The GTP cyclohydrolase I gene in Russian families with dopa-responsive dystonia. , 1998, Archives of neurology.
[12] M. Nitschke,et al. Dopa responsive dystonia with Turner’s syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene , 1998, Journal of neurology, neurosurgery, and psychiatry.
[13] G. Deuschl,et al. High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa‐responsive dystonia , 1998, Annals of neurology.
[14] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[15] R. Fuente-Fernández. Tardive dyskinesia in dopa-responsive dystonia: A reappraisal of the dopamine hypothesis of tardive dyskinesia , 1998 .
[16] Hidefumi Ito,et al. Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene , 1998, Journal of neurology, neurosurgery, and psychiatry.
[17] P. S. St George-Hyslop,et al. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia , 1998, Neurology.
[18] R. Levine,et al. Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia , 1998, Neurology.
[19] J. Kira,et al. A novel mutation of the GTP‐cyclohydrolase I gene in a patient with hereditary progressive dystoniddopa‐responsive dystonia , 1998, Neurology.
[20] G. Kapatos,et al. Nigrostriatal Dopamine Neurons Express Low Levels of GTP Cyclohydrolase I Protein , 1998, Journal of Neurochemistry.
[21] N. Risch,et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein , 1997, Nature Genetics.
[22] C. Marsden,et al. GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs , 1997, Journal of neurology, neurosurgery, and psychiatry.
[23] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[24] S. Ueno,et al. Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. , 1997, Biochemical and biophysical research communications.
[25] E. Bebin,et al. Oral phenylalanine loading in dopa‐responsive dystonia , 1997, Neurology.
[26] N. Blau,et al. Mutations in the GTP cyclohydrolase I and 6‐pyruvoyl‐tetrahydropterin synthase genes , 1997, Human mutation.
[27] H. Ito,et al. Mutant GTP cyclohydrolase I mRNA levels contribute to dopa‐responsive dystonia onset , 1996, Annals of neurology.
[28] E. Hirsch,et al. New Species of Human Tyrosine Hydroxylase mRNA Are Produced in Variable Amounts in Adrenal Medulla and Are Overexpressed in Progressive Supranuclear Palsy , 1996, Journal of neurochemistry.
[29] R. Surtees,et al. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. , 1996, Human molecular genetics.
[30] S. Kish,et al. Dopa-responsive Dystonia , 2004 .
[31] C. Marsden,et al. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. , 1996, Human molecular genetics.
[32] H. Ito,et al. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. , 1995, Biochemical and biophysical research communications.
[33] J. Mallet,et al. Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. , 1995, Human molecular genetics.
[34] N. Blau,et al. Characterization of Mouse and Human GTP Cyclohydrolase I Genes , 1995, The Journal of Biological Chemistry.
[35] R. Palmiter,et al. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development , 1995, Nature.
[36] D. Weeks,et al. The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q , 1995, Annals of Neurology.
[37] X. Breakefield,et al. Co-factor insufficiency in Dystonia-Parkinsonian syndrome , 1994, Nature Genetics.
[38] S. Tsuji,et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.
[39] R. Levine,et al. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa‐responsive dystonia , 1994, Annals of neurology.
[40] Stanley Fahn,et al. Linkage mapping of dopa–responsive dystonia (DRD) to chromosome 14q , 1993, Nature Genetics.
[41] H. Hidaka,et al. Structure of the mouse tyrosine hydroxylase gene. , 1992, Biochemical and biophysical research communications.
[42] T. Sasaoka,et al. Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. , 1991, Biochemical and biophysical research communications.
[43] N. Toshiharu,et al. Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals , 1991 .
[44] W. Görke,et al. Biochemical and neurophysiological investigations in two forms of Segawa's disease. , 1990, Neuropediatrics.
[45] C. Nathan,et al. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. , 1989, The Journal of biological chemistry.
[46] M. Marletta,et al. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. , 1989, The Journal of biological chemistry.
[47] Y. Kurosawa,et al. Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. , 1988, Journal of biochemistry.
[48] M. Hallett,et al. Dystonia with marked diurnal variation associated with biopterin deficiency , 1988, Neurology.
[49] S. Boularand,et al. Analysis of the 5’Region of the Human Tyrosine Hydroxylase Gene: Combinatorial Patterns of Exon Splicing Generate Multiple Regulated Tyrosine Hydroxylase Isoforms , 1988, Journal of neurochemistry.
[50] Y. Kurosawa,et al. Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. , 1987, Biochemical and biophysical research communications.
[51] J. Mallet,et al. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics , 1987, Nature.
[52] W. Lovenberg,et al. Tetrahydrobiopterin in dystonia , 1986, Neurology.
[53] N. Blau,et al. Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: detection of heterozygotes of GTP cyclohydrolase I deficiency. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[54] R. Levine,et al. LOW CSF HYDROXYLASE COFACTOR (TETRAHYDROBIOPTERIN) LEVELS IN INHERITED DYSTONIA , 1979, The Lancet.
[55] W. Lovenberg,et al. Tryptophan Hydroxylation: Measurement in Pineal Gland, Brainstem, and Carcinoid Tumor , 1967, Science.
[56] A. Sjoerdsma,et al. ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. , 1965, The Journal of pharmacology and experimental therapeutics.
[57] S. Udenfriend,et al. TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.
[58] S. Kaufman. THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR. , 1962, Proceedings of the National Academy of Sciences of the United States of America.